Navigation Links
Zix Corporation Reports Another Record-High Revenue Quarter as Company Announces Second Quarter 2009 Financial Results
Date:7/28/2009

undled solutions
  • ZixCorp announced enhancements to its Email Encryption service, including the introduction of two new filters to comply with recent state privacy regulations in Massachusetts and Nevada
  • The Company launched a series of well-attended compliance webinars on topics including state privacy laws and enhancements to HIPAA in the American Recovery and Reinvestment Act
  • ZixCorp entered into an OEM partnership with Webroot, who announced that it was embedding ZixCorp's Email Encryption service into the Webroot Email Security SaaS

    • e-Prescribing

    • e-Prescribing revenue for second quarter 2009 was $1.0 million, down 23 percent when compared with the same quarter in 2008
    • The Company's PocketScript business met the e-Prescribing deployment guidance of 300 to 350 for the second quarter with 325 deployments
    • ZixCorp processed over 2.5 million e-scripts in the second quarter, an increase of approximately 19 percent over the second quarter of 2008
    • ZixCorp's PocketScript( )e-Prescribing service is among the options available to physicians on a new American Medical Association (AMA) online vendor selection tool
    • ZixCorp announced earlier that it had retained Allen & Co to assist the Company's Board of Directors in reviewing strategic alternatives for maximizing the shareholder value of its e-Prescribing business

    Financial Highlights

    Note: All gross profit and expenditure explanations below are based on adjusted non-GAAP amounts, the primary adjustments of which are non-cash stock-based compensation under SFAS 123R and non-recurring expense items- see "Use of Non-GAAP Financial Information" below and the "Reconciliation of GAAP to Non-GAAP Financial Measures" presented with attached financial statements.

    R
    '/>"/>

    SOURCE Zix Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    1

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine news :

    1. DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call
    2. Danaher Corporation Announces Retirement of Executive Vice President Philip W. Knisely
    3. Dialysis Corporation of America Announces Second Quarter 2009 Earnings Release Date
    4. Providence Service Corporation to Report Second Quarter 2009 Results on Monday, August 10th After the Market Closes
    5. MedCath Corporation to Hold Conference Call on Third Quarter Results
    6. Digirad Corporation Reports Second Quarter 2009 Financial Results
    7. Service Corporation International Announces Schedule For Its Second Quarter 2009 Earnings Release and Conference Call
    8. Quigley Corporation Announces Final Results of Quigley Pharmas Phase IIb Study
    9. Align Technology Provides Update on Patent Litigation with Ormco Corporation
    10. PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009
    11. PTS, Inc. Subsidiary Disability Access Corporation Announces $535,000 in New Contracts and Inspection Orders for July 2009

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2009)...TheAmericanSocietyofEchocardiography(ASE)hasreleas...0CMSPhysicianFeeSchedule(PFS)onpatientsandpractice...ndtechnicianssurveyed,87percentsaidthenewfeeschedu...ducestafforshutdowntheirpracticecompletely--ultima...ltrasound)andothervitalservices. ,, Onecardiacs...
    (Date:11/24/2009)...tCall/--RegeneronPharmaceuticals,Inc.(Nasdaq: REGN...ffrayHealthcareConferenceonTuesday,December1,2009....hesessionmaybeaccessedthroughtheCompany,swebsite, ...chivedversionofthepresentationwillbeavailableafter...ormationaboutRegeneronandrecentnewsreleasesareavai...
    (Date:11/24/2009)...eezing, study finds , , TUESDAY, Nov. 24...affic pollution and indoor endotoxin are at increa...in -- a component of bacteria believed to trigger ..., University of Cincinnati College of Medicine ...rning sign of asthma and other lung conditions) in...
    (Date:11/24/2009)... likely to become disabled, study finds , ...hildren may slow the progression of multiple scler...hers followed 330 women who had experienced their ..., Women who had given birth to at least one chil...progress to a stage in which they needed walking a...
    (Date:11/24/2009)...diaMediTechCompany,aleading,pharmaceuticalR&Do...thatthecompanyreceivedtheRedHerringAsiaTop100Enter...hnologycompaniesintheAsiaPacific,region. , Re...rvarious,regions,suchasNorthAmerica,Europe,andAsia...ttherequirementsofcutting-edgetechnology,andoutsta...
    Breaking Medicine News(10 mins):Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Traffic, Dust Linked to Asthma in Kids 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 3
    ...n-anemic women between ages 18 and 55 with unexpla...d to women with low ferritin, a protein that store...leen. Researchers from the University of Lausan...decreased by 29 percent in the iron group compared...
    ...ntrol and Prevention has reported a global fall in...s a contagious disease and is the fifth leading ca...is has largely been possible due to improved vacci...t in the developing countries.// According to repo...
    ...ases Monday, the smallest number of new cases sinc...ports on the spread of the SARS epidemic last mont...in Beijing and Inner Mongolia, bringing China's de...w death and one// infection Monday. The epidemic h...
    ...ne that might be responsible for asthma. Scientist...g of the disease, hence leading to better treatme...ant effect on a person's susceptibility to asthma...some that was known to contain an asthma-related g...
    ...are often caused by bacteria and are frequently tr...Fluoroquinolones have been recommended empirical t... indicates that Ciprofloxacin has high activity ag...ly treatment option for these difficult-to treat i...
    ...ic illness could be triggered by abortion. However...ctic from the anti-abortion movement. Researchers ...ancies were more likely to be hospitalised for psy...who had an abortion were nearly three times more l...
    Other Medicine News:
    (Date:11/24/2009)...O,Nov.24/PRNewswire-FirstCall/--Orexigen®Ther...panyfocusedonthetreatmentofobesity,todayannouncedt...ompany,sBoardofDirectorsgrantedaninducementstockop...lassen,M.D.,itsnewlyappointedHeadoftheGlobalContra...entivestockoptiontotheextentpermittedbylawandhasan...
    (Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--KeryxBiopharmaceuti...ur,theCompany,sChiefExecutiveOfficer,isscheduledto...encebeingheldinNewYorkCity. ,, Mr.Bentsur,spres...10:30AMETandwillbeaccessiblefromtheInvestorInforma...eryx.com .Anarchivedversionofthewebcastwillbeavail...
    (Date:11/23/2009)...ATI,Nov.23/PRNewswire-FirstCall/--HealthWarehouse....derpharmacy,todayannounceditsfinancialresultsforth...tedquarterlyrevenueof$1,006,721,drivenbyheavygrowt...insincreased13.0%year-over-yearto34.6%andthenetlos...299forthethreemonthsendedSeptember30,2008. ,, "...
    Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3blue sky scrubs adds Caribbean Blue Scrubs 61357 1blue sky scrubs adds Caribbean Blue Scrubs 61357 2TET Systems and Novo Nordisk sign license agreement 10723 1TET Systems and Novo Nordisk sign license agreement 10723 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 1Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 3
    ... - New Study Demonstrated the Clinical Potential o...s, Which Were as Effective as,Avastin(R) in Animal...Newswire-FirstCall/ --,Peregrine Pharmaceuticals, ...developing targeted monoclonal antibodies,for the ...n, today,reported that data from multiple studies ...
    ... LOS ANGELES--(BUSINESS WIRE)--Apr 23, 2007 - CytR...he RNA interference (RNAi),delivery technology exc..., RXi Pharmaceuticals Corporation (RXi), has been,... scientific,journal ACS Chemical Biology. The tech... Advisory Board member and University of,Massachus...
    Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
    Roche COMPACT 3 Blood Gas Analyzer
    GEM® Premier™ 3000 with iQM™
    ABL800 FLEX Blood Gas Analyzer
    AGIT1006 Agitator
    Medicine Products: